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Abstract
Background: PGF2alpha exerts a significant contractile effect on myometrium and is central to
human labour. THG113.31, a specific non-competitive PGF2alpha receptor (FP) antagonist, exerts
an inhibitory effect on myometrial contractility. The BKCa channel is ubiquitously encountered in
human uterine tissue and plays a significant role in modulating myometrial cell membrane potential
and excitability. The objective of this study was to investigate potential BKCa channel involvement
in the response of human myometrium to THG113.31.
Methods:  Single and whole-cell electrophysiological BKCa channel recordings from freshly
dispersed myocytes, were investigated in the presence and absence of THG113.31. Functional
studies investigated the effects of THG113.31 on isolated spontaneous myometrial contractions, in
the presence and absence of the BKCa channel blocker, iberiotoxin.
Results:  Single channel recordings identified the BKCa channel as a target of THG113.31.
THG113.31 significantly increased the open state probability of these channels [control 0.023+/-
0.006; 10 microM THG113.31 0.087+/-0.012 (P = 0.009); and 50 microM THG113.31 0.1356+/-
0.018 (P = 0.001)]. In addition, THG113.31 increased whole-cell BKCa currents over a range of
membrane potentials, and this effect was reversed by 100 nanoM IbTX. Isometric tension studies
demonstrated that THG113.31 exerted a significant concentration-dependent relaxant effect on
human myometrial tissue and pre-incubation of strips with IbTX abolished this effect on
spontaneously occurring contractions.
Conclusion: These data suggests that activation of the BKCa channel may contribute, at least
partially, to the uterorelaxant effect of THG113.31.
Background
The mechanisms underlying the onset and maintenance
of human parturition are poorly understood [1,2]. During
pregnancy and labour the uterus undergoes dramatic
changes in its contractile activity when it is transformed
from a relatively quiescent state during pregnancy to a
state of maximal contractile activity at labour onset. The
exact regulatory mechanisms for this process are unclear
[3,4], but what is well established, is that abnormalities of
this process have major clinical implications. Preterm
labour is the single largest cause of perinatal mortality in
developed countries and is a major contributor to neona-
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tal morbidity and childhood developmental problems
[1,5,6]. In addition, these problems constitute an
immense cost to healthcare resources.
PGF2α plays a pivotal role in parturition [7-9]. It is the
most effective smooth muscle contractile prostaglandin
[7], which exerts a significant stimulatory effect on the
myometrium [10], and is a potent compound for induc-
ing labour [8]. A significant rise in PGF2α levels occurs in
the amniotic fluid during early labour [11]. A rise in
PGF2α levels results in stimulation of myometrial contrac-
tions in various species [10,12]. Inhibition of prostaglan-
din formation results in reduced myometrial contractions
and prolonged labour [13] and disruption of the PGF2α
receptor gene leads to failure of animals to go into labour
[14]. THG113 has recently been reported as a selective,
non-competitive, reversible, and potent FP receptor antag-
onist [8,9]. A version of the FP receptor antagonist,
THG113.31 has recently been reported to significantly
delay preterm labour in an endotoxin-induced preterm
labour mouse model [8], providing the basis for future
investigations for its use in tocolysis. In vitro functional
studies, from our laboratory, support this tocolytic effect
by demonstrating that THG113.31 exerted a potent con-
centration dependent relaxant effect on both spontaneous
and oxytocin induced contractions, in human myometrial
tissue [15,16].
The nature by which THG113.31 inhibits contractions in
the uterus has yet to be elucidated. A primary determinant
of smooth muscle tone and contractility is the resting
membrane potential, which, in turn, is influenced heavily
by K+ channel activity [17,18]. The large conductance cal-
cium-activated potassium channel (BKCa) is the predomi-
nant K+ channel type in both non-pregnant and pregnant
human myometrium [19-23] and plays an important role
in suppressing myometrial activity during gestation [22].
This channel is considered to be relatively easy to identify
and study, using electrophysiological single channel and
whole cell patch clamp methodologies due to its large sin-
gle channel conductance (> 200 pS in symmetrical K+ gra-
dients) and its pharmacological sensitivity to the
extracellular blockers tetraethylammonium, charyb-
dotoxin and iberiotoxin (IbTX).
We sought to investigate whether the BKCa channel was a
target site for THG113.31 activity. Using single channel
electrophysiological recordings we determined the effects
of THG113.31 on the open state probability of BKCachan-
nels in human uterine myocytes, and evaluated if the
relaxant effect of THG113.31 on spontaneous myometrial
contractions was altered by BKCa blockade, in functional
studies, using IbTX.
Materials and methods
Tissue collection
Biopsies of human myometrium were obtained from 26
women undergoing elective cesarean section in the third
trimester of pregnancy, in the Department of Obstetrics
and Gynecology, University College Hospital, Galway,
Ireland. The reasons for caesarean section included breech
presentation, previous cesarean section and medical con-
ditions, such as maternal spina bifida, maternal pelvic dis-
order and placenta praevia. All cesarean sections were
performed prior to the onset of labour under regional
anesthesia. The maternal demographic details were as fol-
lows: mean age 34 years (range 22–42); median period of
gestation 39 weeks (range 37–40); and median parity 1
(range 0–5).
Biopsies were excised from the midline portion of the
upper lip of the incision in the lower uterine segment.
Women who had received exogenous prostaglandins, oxy-
tocin or corticosteroids were excluded from the study.
Recruitment was by written informed consent. Ethics
committee approval for the study was obtained from the
Research Ethics Committee, University College Hospital,
Galway. For electrophysiological studies tissue samples
were immediately placed in sterile Ham's F-12 medium
(Sigma-Aldrich, Dublin, Ireland), supplemented with 100
Uml-1 penicillin and 100μg ml-1 streptomycin (Sigma-
Aldrich, Dublin, Ireland). Tissue samples for isometric
recordings were placed in fresh Krebs-Henseleit physio-
logic saline solution (PSS) of the following composition
(mM): 4.7 KCl, 118 NaCl; 1.2 MgSO4, 1.2 CaCl2, 1.2
KH2PO4, 25 NaHCO3, and 11 glucose (Sigma-Aldrich,
Dublin, Ireland). Tissue was stored at 4°C and used
within 6 hours of collection.
Tissue dispersion/primary human myometrial cells
The preparation of single myometrial cells for electro-
physiological recordings was performed using methodol-
ogy previously described [24]. Freshly isolated
myometrial cells were obtained by enzymatic digestion of
finely minced myometrium with 2 mg ml-1 collagenase
(type IA, 300–400 U mg-1) (Sigma-Aldrich, Dublin, Ire-
land) in Hanks buffered salt solution. The incubation
with enzyme was performed @ 37°C for 2 hrs followed
by centrifugation (1000 revs min-1) in 50% Percoll
(Sigma-Aldrich, Dublin, Ireland) for 10 minutes. The cell
layer was removed, washed, and spun in physiological
solution to remove excess red blood cells. The cell suspen-
sion was then triturated and filtered through an 80 μm
nylon mesh filter. Single cells were placed in a recording
chamber (Warner Instrument Corporation, Hamden, CT
06514, USA) and electrophysiological experiments begun
immediately. Morphologically, freshly dissociated uterine
myocytes were characterized by a long, slender fusiform
shape. All myocytes used for this work were relaxed andReproductive Biology and Endocrinology 2007, 5:10 http://www.rbej.com/content/5/1/10
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adhered to the bottom of the recording chamber with no
additional substrate.
Electrophysiological recordings of the BKCa channel
Single channel recordings using the cell-attached configu-
ration of the patch clamp technique were performed. Sev-
eral drops of cell suspension were placed in the recording
chamber containing a solution of the following composi-
tion (mM): 140 KCl, 10 MgCl2, 0.1 CaCl2, 10 HEPES, and
30 glucose (pH 7.4, 22–25°C). Single potassium channel
currents were measured in cell-attached patches by filling
the patch pipette (2–5 MΩ) with Ringer solution com-
posed of (mM); 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, and
10 HEPES, and making a gigaohm seal on a single myo-
cyte. Voltage across the patch was controlled by setting the
cellular membrane potential to 0 mV using a high- [K+]
extracellular solution. Average channel activity in patches
was measured as mean open probability (NPo). The
effects of THG113.31 (10 and 50 μM) on channel activity
were measured by recording ~10 seconds of continuous
recording at +40 mV, before and 15 minutes after drug
treatment. Currents were filtered at 1 kHz and digitised at
10 kHz. In all experiments voltage-clamp and voltage-
pulse generation were controlled with an Axopatch 200-A
patch-clamp amplifier (Axon Instruments, Union City,
California, USA), and data was acquired and analysed
with pClamp 8. For statistical purposes, and to ensure
accuracy, NPo was calculated for single BKCa channels at a
depolarised potential where channel openings can be
clearly differentiated from other channel species. BKCa
channels are easily visualised at + 40 mV as there is virtu-
ally no "contamination" with other channel species [25].
In addition, at such depolarised voltages, there is no other
ion channel expressed in these cells with an amplitude of
7–9 pA, making statistical analysis of BKCa channel activ-
ity more accurate [25]. Moreover, recording single chan-
nel activity at more depolarised potentials helps
compensate the artificial depression of activity otherwise
encountered from recording channel activity at room tem-
perature (22–25°C) [25].
In a separate set of experiments the direct effect of PGF2α
on BKCa channel activity was investigated. Cells were pre-
incubated with 20 μM NS1619, the specific channel
opener, for 15 minutes before cell-attached recordings
were taken and the effect of PGF2α, in the presence of
NS1619 was determined (n = 4). Furthermore, in addi-
tional experiments, myometrial cells were pre-incubated
with 1 μM PGF2α, cell-attached recordings were taken and
the effect of 10 μM THG113.31 on channel activity was
again measured (n = 3).
For perforated patch experiments, the recording chamber
contained a bath solution of the following composition
(mM): 140 NaCl, 5 KCl, 1 CaCl2, 2 MgCl2, 10 HEPES, and
30 glucose (pH 7.4; 22–25°C). To measure potassium
currents, the tip of the patch pipette (1–5 mM) was filled
with a solution containing (mM): 60 K2SO4, 30 KCl, 5
MgCl2, 5 CaCl2, 5 mm HEPES, and 40 mm MgSO4 (pH
7.4). Because divalent ions do not pass through pores in
the perforated membrane, the high Ca2+ in the pipette
solution does not enter the cell, thus obviating the need
for artificial Ca2+ buffers. In contrast, the K+ channels were
always exposed to physiological levels of Ca2+ (bath solu-
tion) in these whole-cell recording experiments and not
the 5 mmol of the pipette solution. The remainder of the
pipette was back-filled with the same solution to which 6
mg/ml amphotericin B (diluted by sonication from a 50
mg/ml stock in dimethylsulfoxide) was added. Genera-
tion of voltage clamp protocols and acquisition of data
were carried out using pClamp software (version 8). Volt-
age-activated currents were filtered at 1 kHz and digitized
at 10 KHz. Leakage currents were algorithmically sub-
tracted using short duration, small amplitude negative
prepulses.
Isometric tension recordings
Longitudinal myometrial strips (measuring approxi-
mately 2 × 2 × 10 mm) were dissected free from uterine
decidua and serosa and mounted isometrically in an
organ tissue bath under 2 g tension for recordings, as pre-
viously described [24]. The tissue baths contained 20 ml
of Krebs-Henseleit PSS maintained at 37°C, pH 7.4, and
were gassed continuously with a mixture of 95% oxygen/
5% carbon dioxide. During a period of equilibration of
one hour, the Krebs-Henseleit PSS in the tissue baths was
changed every 15 minutes. The experiments evaluating
effects on spontaneous myometrial contractility were
designed into 4 subgroups as follows: Group 1. spontane-
ous alone; Group 2. spontaneous + THG113.31; Group 3.
spontaneous + IbTX; Group 4. spontaneous + IbTX +
THG113.31. After 30 minutes, strips from Groups 3, and
4 were exposed to IbTX at a bath concentration of 100 nM
for a further 30 minutes, while Group 1 and 2 strips were
exposed to Krebs-Henseleit PSS only. Contractile activity
was measured for a 20- minute period at which time bath
addition of THG113.31 to Group 2 and 4 strips took
place. Highly purified THG113.31 was added to the tissue
bath in a cumulative manner at bath concentrations 1 nM,
10 nM, 100 nM, 1 μM and 10 μM at 20 minute intervals,
and the resultant contractile activity was measured for
each period and expressed as a percentage of the integral
obtained in the 20 minute period prior to any THG113.31
addition (i.e. percentage of contractility). Measurement of
contractile activity was performed by calculation of the
integral of the selected area with the PowerLab (AD Instru-
ments, Hastings, UK) hardware unit and Chart v3.6 soft-
ware (AD Instruments, Hastings, UK).Reproductive Biology and Endocrinology 2007, 5:10 http://www.rbej.com/content/5/1/10
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Drugs and solutions
THG113.31 was obtained as a gift from Dr Krishna Peri,
Theratechnologies, Quebec, Canada. A stock solution (1
mM) was made in deionised water. Serial dilutions were
prepared in deionised water and stored at room tempera-
ture. A stock solution of IbTX (Sigma-Aldrich, Dublin, Ire-
land) (1 × 10-5 M) was made in saline. Fresh Krebs-
Henseleit PSS was prepared daily. All other chemicals
were obtained from Sigma-Aldrich, Dublin, Ireland.
Data and statistical analysis
For single channel activity data NPo values are expressed
as mean ± standard error of the mean. Comparisons
between groups were made by one-way analysis of vari-
ance (ANOVA), followed by a post-hoc Tukey HSD test to
determine significant differences among data groups. Cur-
rents were filtered at 2 kHz and digitized at 10 kHz. Aver-
age channel activity in patches with multiple BKCa
channels determined by:
NPO = Σn
j = 1 tj J/T
where Po is the single-channel open-state probability, T is
the duration of the recording, tj is the duration of j = 1,2,
..... n channel openings, J is the number of channels open
for duration tj, and N is the maximal number of simulta-
neous channel openings observed when Po was high.
For isometric recordings, using the calculated integrals of
contractile activity at each bath concentration dose
response curves were analysed by fitting the sigmoidal
dose-response equation:
Y = Ymax x Dn
H/EC50 + Dn
H
Where Y is the response (percentage contractility), Ymax is
the maximal relaxation achieved, D is the dose of agonist
(THG113.31),  n
H is the slope function, and EC50 is the
agonist dose giving the half maximal response. Curve fit-
ting was performed with the software package Prism
(Graphpad Software, San Diego, California, USA). Multi-
ple comparisons of measured integrals of contractility
were performed using two-way ANOVA, followed by post-
hoc Tukey test. The statistical packages SPSS Version 11.0
(Chicago, Illinois, USA) and SigmaStat Version 2.0 (SPSS
Inc., Chicago, USA) were used for statistical calculations.
A P value < 0.05 was accepted as statistically significant.
Results
BKCa channel identification
Single-channel recordings from freshly dispersed myo-
cytes, using the cell-attached configuration of the patch
clamp technique, revealed membrane electrical activity to
be dominated by a prominent, large conductance (152 ±
19.30 pS (n = 6) physiological gradients of potassium;
range 115–206 pS) channel carrying outward potassium
currents. Channel activity recorded, from a cell attached
patch, with an amplitude range of 6–10 pA at +40 mV,
under control conditions revealed minimal gating events
(NPo = 0.034 ± 0.006; n = 3). In contrast, exposure to
NS1619, a specific BKCa channel opener, elicited potent
channel activation at applied concentration of 20 μM,
(0.103 ± 0.0196 (n = 3); (Figure 1)). Subsequent addition
of IbTX (100 nM), a specific extracellular BKCa channel
blocker, reversed NS1619-stimulated channel activity.
These properties, the conductance value, NS1619- and
IbTX- sensitivity are in accordance with the characteristics
of the BKCa  channels in smooth muscle myocytes
described in literature [26,27]. Therefore, we identified
this protein as the high-conductance, NS1619-and IbTX-
sensitive BKCa channel, which is the predominant K+ chan-
nel species in human myometrial smooth muscle [19-23].
BKCa channel activity
A representative recording, demonstrating minimum
BKCa channel activity under control conditions (NPo =
0.022), is shown in Figure 2A. Cumulative additions of
THG113.31 resulted in a potent activation of BKCa chan-
nel activity in a concentration-dependent fashion, as illus-
trated (Figure 2B &2C). BKCa channel activity for this
recording was increased following the addition of 10 (NPo
= 0.102) and 50 (NPo = 0.191) μM THG113.31, respec-
tively (Figure 3A). The average NPo (Figure 3B) before and
after addition of THG113.31 was as follows: control 0.023
± 0.007 (n = 6); 10 μM THG113.31 0.087 ± 0.012 (n = 6;
P = 0.005) and 50 μM THG113.31 0.136 ± 0.018 (n = 6; P
= 0.001). THG113 .31 stimulated the BKCa channel with a
maximal activation effect observed at the highest concen-
tration of 50 μM THG113.31. Open state channel activity
was stimulated on average 4 and 6-fold by 10 and 50 μM
THG113.31 respectively. In general, there was a 5–10
minute latency period prior to observation of
THG113.31-stimulated channel activity, and this effect
appeared to be maximal within 10–15 minutes. In all
patches this activity persisted until either seal integrity was
lost, or the experiment was terminated.
A further set of experiments on cell-attached patches indi-
cated that the stimulatory effect observed with
THG113.31 was not mediated via the PGF2α receptor (Fig-
ure 4). PGF2α failed to have any effect on BKCa channel
activity after pre-icubation of the cells with NS1619 as
seen in Figure 4A. The average NPo before and after addi-
tion of NS1619 and further application of PGF2α was as
follows: control 0.028 ± 0.001 (n = 4), 20 μM NS1619
0.111 ± 0.022 (n = 4; P = 0.016), 1 μM PGF2α 0.142 ± 0.03
(n = 4; P = 0.04). The average effects are summarized in
Figure 4B. Furthermore, pre-incubation with PGF2α had
no effect on the stimulatory effect observed with
THG113.31 as illustrated in Figure 4C and 4D. The typicalReproductive Biology and Endocrinology 2007, 5:10 http://www.rbej.com/content/5/1/10
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response to THG113.31 in the presence of PGF2α, is illus-
trated by the traces in Figure 4C. The average effects are
summarized in Figure 4D. BKCa channel activity remained
unchanged after 15 minutes exposure to PGF2α, when
compared to control channel activity. The average NPo
before and after addition of PGF2α and further application
of THG113.31 was as follows: control 0.01 ± 0.001 (n =
3), 1 μM PGF2α 0.015 ± 0.005 (n = 3; P = 0.99) and 10 μM
THG113.31 0.135 ± 0.007 (n = 3; P = 0.0002).
Whole-cell studies from single human uterine myocytes
were performed to further characterize the effects of
BRL37344 on ionic currents. As illustrated in Fig. 1, uter-
ine myocytes exhibited prominent outward currents.
THG113.31 enhances BKCa channel activity in human myometrial smooth muscle cells Figure 2
THG113.31 enhances BKCa channel activity in human myometrial smooth muscle cells. A, B & C Representative continuous 
recordings were recorded from the same cell attached patch (+40 mV) before (control) and 15 min after exposure to 10 & 50 
μM THG113.31, respectively. Channel openings are upward deflections from the baseline (closed state) (dashed line).
A
Control 10 μM  THG113.31 50 μM  THG113.31
B C
NS1619, a putative activator of BKCa channels, and IbTX, a specific BKCa channel blocker, serve to identify the BKCa channel in  human uterine smooth muscle myocytes Figure 1
NS1619, a putative activator of BKCa channels, and IbTX, a specific BKCa channel blocker, serve to identify the BKCa channel in 
human uterine smooth muscle myocytes. Representative recordings from the same membrane patch (+40 mV) in the cell-
attached configuration before and after addition of 20 μM NS1619 and subsequent addition of 100 nM IbTX. IbTX reversed 
NS1619-stimulated channel activity.
10 pA
100 ms
Control 20μM  NS1619 20 μM  NS1619 &
   100 nM  IbTXReproductive Biology and Endocrinology 2007, 5:10 http://www.rbej.com/content/5/1/10
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THG113.31 opens BKCa channel activity in human myometrial smooth muscle cells in a concentration-dependent manner Figure 3
THG113.31 opens BKCa channel activity in human myometrial smooth muscle cells in a concentration-dependent manner. A 
Activity plot of BKCa channel open probability in a single cell-attached patch before and 15 min after exposure to cumulative 
doses of 10 and 50 μM THG113.31. Vertical bars are channel activity during a 100-ms test pulse to +40 mV. Recording time 
under each condition was 10 s, as indicated on the time axis. Breaks in the time axis represent drug incubation periods when 
channel activity was not recorded. Period of drug exposure is indicated by horizontal lines above the histogram. B Each bar 
represents the average channel open probability obtained from cell attached patches (+40 mV) before and 15 min after addi-
tions of 10 and 50 μM THG113.31, respectively. *Significant increase in channel activity compared to control (n = 6; P < 0.005)
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Application of 50 μM THG113.31 increased these steady-
state outward currents at all positive voltages (Figure 5A
&5B). A complete current-voltage relationship illustrating
the stimulatory effect of THG113.31 is presented in Figure
5B. This effect of THG113.31 was observed at all voltages
where outward current was elicited. The effect of
THG113.31 was reversed by 100 nm IbTX. A summary of
the stimulatory effect of 50 μM THG113.31 followed by
application of IbTX is presented in Figure 5C (n = 3).
These whole-cell studies clearly demonstrate that
THG113.31 stimulates outward current in human uterine
smooth muscle cells, and blockage of these outward cur-
rents with IbTX strongly suggests the involvement of the
BKCa channels.
In vitro contractility
THG113.31 exerted a cumulative inhibitory effect on
spontaneous contractions in isolated pregnant human
myometrium (n = 6). Figure 6A demonstrates a represent-
ative recording of spontaneous myometrial contractility
and figure 6B the relaxant effects of cumulative additions
of THG113.31 (1 nM, 10 nM, 100 nM, 1 μM and 10 μM).
Analysis of variance revealed a significant difference in
integrals of contractility measured across the groups of
experiments which on post hoc testing revealed a statisti-
cally significant relaxant effect of THG113.31 at bath con-
centrations of 10 nM (n = 6; P < 0.001), 100 nM (n = 6; P
< 0.001) and 1 μM (n = 6; P < 0.001) and 10 μM
THG113.31 (n = 6; P < 0.001) when compared to respec-
tive control values measured. Pre-incubation of strips with
IbTX, did not significantly alter the integrals of contractile
activity measured (Group 1 versus Group 3; n = 6; P =
0.10), although an increasing trend in frequency was
observed as seen in Figure 6C. Bath exposure of the strips
to IbTX, prior to addition of THG113.31, abolished the
inhibitory effect of THG113.31. Figure 6D represents a
recording demonstrating the effects of pre-incubation
with IbTX, on the uterorelaxant effects of THG113.31.
Comparison of the inhibitory effects of THG113.31 on
spontaneous contractions of myometrial strips, in the
presence or absence of IbTX, revealed a significant differ-
ence across the groups (Group 2 versus Group 4; n = 6; P
PGF2α has no effect on BKCa channel activity Figure 4
PGF2α has no effect on BKCa channel activity. A Representative recordings from the same membrane patch (+40mV) in the cell-
attached configuration after addition of 20 μM NS1619 and subsequent addition of 1 μM PGF2α. PGF2α did not reverse 
NS1619-stimulated channel activity. B Each bar represents the average channel open probability obtained from cell attached 
patches (n = 4; +40 mV) before and 15 min after each addition (n = 4). *Significant increase in channel activity compared to 
control. C & D THG113.31 activates the BKCa channel independently of the FP receptor. Representative recordings from the 
same membrane patch (+40mV) in the cell-attached configuration before and after addition of 1 μM PGF2α and subsequent 
addition of 10 μM THG113.31. Each bar represents the average channel open probability obtained from cell attached patches 
(n = 3; +40 mV) before and 15 min after each addition (n = 3). *Significant increase in channel activity compared to control.
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<0.05). Post hoc analysis demonstrated that IbTX (100
nM) significantly attenuated the uterorelaxant effect of
THG113.31 at all test concentrations, resulting in no sig-
nificant difference when compared with control values
(Group 3 (n = 5) versus Group 4 (n = 6); P > 0.05) at all
THG113.31 bath concentrations.
In Figures 7, the mean effect of cumulative additions of
THG113.31 on spontaneous (n = 6) contractions of myo-
metrial strips, in the presence and absence of IbTX, are
shown in graphical form alongside the integrals observed
in control strips.
Discussion
The results of several studies have suggested that PGF2α
receptors are present in the uterus and play a pivotal role
during human labour. The findings from the present
study demonstrated that THG113.31 induced a rapid,
concentration dependent relaxation on spontaneous
human uterine contractions. These data provide evidence
that activation of the BKCa channels significantly contrib-
uted to the relaxant effect of THG113.31 in the human
myometrium. Myometrial smooth muscle cells are richly
endowed with BKCa channels [19,28,29] and these chan-
nels are important regulators of smooth muscle contractil-
ity [19]. Using the cell-attached configuration of the patch
clamp technique, THG113.31 significantly increased the
open state probability of these channels, in a concentra-
tion-dependent manner. Using the whole-cell configura-
tion, similar findings were confirmed. These results
concur with the data obtained from the isometric tension
recordings. In the functional studies, the uterorelaxant
THG113.31 increases whole-cell currents in human uterine smooth muscle myocytes Figure 5
THG113.31 increases whole-cell currents in human uterine smooth muscle myocytes. A Perforated patch recordings (n = 3) 
from the same myocyte before and 15 min after exposure to 50 μM THG113.31, and then 5–10 min after cumulative addition 
of 100 nM IbTX. Tracings were taken from a range of potentials (-40 to +50 mV), with a holding potential of -60 mV. B The 
complete current (pA)-voltage (mV) relationship for steady-state outward current from the same cell as in A. Treatment con-
ditions are the same as described for control, 50 μM THG113.31, and THG113.31 and 100 nM IbTX. C Average current-volt-
age relationship for uterine myocytes before and after 50 μM THG113.31, and then cumulative addition of 100 nM IbTX. Each 
point represents the mean number of cells ± SEM.
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Effects of THG113.31 on spontaneous myometrial contractions Figure 6
Effects of THG113.31 on spontaneous myometrial contractions. A Representative recordings of spontaneous contractions of 
pregnant human myometrium under control conditions and (B) the effects of cumulative additions of THG113.31 (1 nM, 10 
nM, 100 nM, 1 μM and 10 μM) at 20 min intervals are shown. (C & D) The uterorelaxant effect was significantly attenuated by 
pre-incubation with the BKCa channel antagonist, IbTX
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effect mediated by THG113.31 was evident on spontane-
ously occurring contractions, in human myometrium,
and was significantly attenuated by BKCa channel block-
ade. Hence following pre-incubation with IbTX, the con-
tractility measured after THG113.31 exposure was
statistically different to that of spontaneous control strips
i.e. strips allowed to contract spontaneously in the pres-
ence or absence of IbTX. It is therefore evident that
THG113.31 activates BKCa channel activity. However, our
findings demonstrate no functional coupling of PGF2α
receptors to BKCa channel activity from freshly isolated
human myocytes, using cell-attached single channel
recordings, despite THG113.31 significantly increasing
the open state probability of these channels in a concen-
Dose response curves for THG113.31 and spontaneous myometrial contractions Figure 7
Dose response curves for THG113.31 and spontaneous myometrial contractions. Graphical representation of the effects of 
cumulatively increasing tissue bath concentrations of THG113.31 (1 nM, 10 nM, 100 nM, 1 μM and 10 μM) at 20 min intervals 
on spontaneous (shaded circle) contracting pregnant myometrium in the presence (shaded triangle) and absence (shaded 
square) of IbTX. A control trace showing uninterrupted spontaneous contractions in pregnant myometrium in the presence 
(open square) and absence (shaded circle) of IbTX, are shown for comparison. The symbols used represent the mean values (n 
= 6) within each group. Vertical error bars represent the standard error of the mean.
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tration-dependent manner. One explanation is that the
effect of THG113.31 on these channels has little to do
with its activity at the FP receptor. PGF2α was demon-
strated to have no direct effect on the activity of these BKCa
channels. The most plausible conclusion is that the BKCa
channel effect of THG113.31 exists independently of its
putative PGF2α blockade role.
These findings, therefore, indicate that PGF2α receptor
antagonism induces uterorelaxation, at least partially, via
activation of BKCachannel activity. The possibility of other
signalling pathways and/or other mechanisms of action,
however, do also exist. The other effector mechanisms or
signalling pathways involved in this process, however,
were not addressed during this study. This remains an
exciting study requiring further evaluation.
Spontaneous contractions indigenous to the smooth mus-
cle, may occur at different frequencies in myometrial
smooth muscle strips. For this reason control experiments
were run simultaneously for all strips. It is our view that
contractions indigenous to the myometrium, once prop-
erly controlled for, provide a good model of in vitro con-
tractility in investigating a utero-relaxant compound and
its potential antagonist. The other option is to use a model
of agonist- (eg. oxytocin, endothelin) induced contrac-
tions, which are commonly used [30] but for these exper-
iments, where IbTX was also added, it was preferable to
use spontaneous contractions only.
Conclusion
In conclusion, this is the first report which demonstrates
that THG113-mediated relaxation of human pregnant
myometrium appears to involve, at least in part the open-
ing of uterine BKCa channels. However, this uterorelaxant
effect of THG113.31 does not appear to be functionally
linked to PGF2α or its receptor, FP. Finally, these findings
support the possibility that THG113.31 may confer thera-
peutic benefit in preterm labour management, by a mech-
anism that appears to be mediated by BKCa  channel
activity.
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